Late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation

Pietro E. Cippà, Jing Liu, Bo Sun, Sanjeev Kumar, Maarten Naesens, Andrew P. McMahonbioRxiv 2018 · DOI

Abstract

The mechanisms initiating the late immune response to allografts are poorly understood. Through transcriptome analysis of serial protocol biopsies in kidney transplant recipients, we found a tight correlation between the initial response to kidney injury and a late B lymphocyte signature associated with renal dysfunction and fibrosis, suggesting a link between dysfunctional repair and immunoreactivity. To specifically investigate the immunological consequences of dysfunctional repair, we followed the mouse kidney up to 18 months after ischemia/reperfusion. Even in the absence of foreign antigens, we identified a sustained immune response in conjunction with the transition to chronic kidney damage. This tissue-driven immunological process involved both the innate and the adaptive immune system and eventually induced an antigen-driven proliferation, selection, and maturation of B lymphocytes into broadly-reacting antibody-secreting cells. These findings reveal an unappreciated role of dysfunctional tissue repair on local immunoregulation with a particular relevance for late transplantation immunobiology.

Introduction

Despite significant advancements in immunosuppressive therapies, long-term outcomes for kidney transplant recipients have largely stagnated. Approximately 4–5% of grafts are lost annually after the first year, a phenomenon traditionally attributed to "chronic rejection"—the immune system's persistent attack on foreign donor tissue. However, the precise triggers for this late-stage immune activation often remain elusive.

This research, originally published in Nature Communications, challenges the conventional paradigm by suggesting that chronic failure may not be driven solely by the "foreignness" of the organ. Instead, the study proposes that the organ’s own failed attempt to repair itself after the initial injury sustained during transplantation (ischemia/reperfusion injury) creates a localized, autoimmune-like environment. This "maladaptive" repair program recruits and matures B lymphocytes, leading to a self-sustaining cycle of inflammation and fibrosis.

The Maladaptive Injury Repair (MIR) Signature

To understand the transition from acute injury to chronic failure, the researchers conducted a dual-track study combining human clinical data with a long-term mouse model. In the human cohort, transcriptome analysis (RNAseq) was performed on serial biopsies from 42 kidney transplant recipients at baseline, 3 months, and 12 months post-transplant.

Using t-SNE and cluster analysis, the researchers identified a distinct group of patients exhibiting a "Maladaptive Injury Repair" (MIR) signature. At the 3-month mark—well before clinical signs of rejection typically manifest—these patients already showed molecular evidence of sustained injury and failed repair. Crucially, this early signature of acute injury was a powerful predictor of B cell activity and significant fibrosis at the 12-month mark. Patients in the MIR group demonstrated lower renal function (eGFR) and higher histological scores for fibrosis (ci and ct scores) compared to their counterparts.

From Innate to Adaptive: The Mouse IRI Model

To isolate the effects of tissue injury from the confounding variables of foreign antigens (alloantigens), the team utilized a mouse model of ischemia/reperfusion injury (IRI), following the subjects for up to 18 months. Because this model involves no foreign tissue, any observed immune response is purely a reaction to the injury and subsequent repair process.

While myeloid cells (innate immunity) dominated the acute phase immediately following injury, the researchers observed a dramatic shift over time. By 6 months post-injury, lymphocytes (adaptive immunity) became the most abundant immune cells in the damaged tissue. The injured kidneys began to organize themselves into Tertiary Lymphoid Organs (TLOs)—ectopic immune centers containing B cell zones and germinal centers. This suggests that the damaged kidney itself acts as a site for immune cell education and activation.

B Cell Maturation and Autoimmunity

Using advanced analytics, including BCR (B cell receptor) repertoire analysis and Translating Ribosomal Affinity Purification (TRAP), the study tracked the behavior of these localized B cells. The results indicated that B cells were not merely passive bystanders; they were undergoing targeted clonal expansion and affinity maturation within the kidney. By 12 months post-injury, a small number of B cell clones dominated the kidney's immune landscape, with the top three "V segments" accounting for nearly 40% of all B cell transcripts.

Most strikingly, 16 months after the initial injury, the mice exhibited a significant increase in antibodies against 35 out of 118 tested autoantigens, including Collagen IV and DNA Polymerase Beta. This confirms that severe tissue injury alone, in the absence of any foreign organ, is sufficient to trigger a sophisticated, antigen-driven B cell response that eventually targets the body's own tissues.

Discussion and Clinical Implications

This study redefines the relationship between injury and immunity in the context of transplantation. It proposes a deleterious feedback loop: severe initial injury leads to dysfunctional repair, which in turn creates a pro-inflammatory niche that recruits B cells. These B cells mature and produce autoantibodies, further damaging the tissue and perpetuating the cycle of fibrosis.

While the human sample size was relatively small, the implications for clinical practice are significant. If "MIR" patients can be identified early—perhaps at the 3-month mark—through molecular signatures, clinicians may be able to implement targeted therapies to dampen the early injury response. By intervening before the transition to an adaptive immune response, it may be possible to prevent the progression to chronic, immune-mediated graft failure and improve long-term outcomes for transplant recipients.

Summary updated

Abstract

Abstract The mechanisms initiating the late immune response to allografts are poorly understood. Through transcriptome analysis of serial protocol biopsies in kidney transplant recipients, we found a tight correlation between the initial response to kidney injury and a late B lymphocyte signature associated with renal dysfunction and fibrosis, suggesting a link between dysfunctional repair and immunoreactivity. To specifically investigate the immunological consequences of dysfunctional repair, we followed the mouse kidney up to 18 months after ischemia/reperfusion. Even in the absence of foreign antigens we identified a sustained immune response in conjunction with the transition to chronic kidney damage. This tissue-driven immunological process involved both the innate and the adaptive immune system and eventually induced an antigen-driven proliferation, selection and maturation of B lymphocytes into broadly-reacting antibody secreting cells. These findings reveal an unappreciated role of dysfunctional tissue repair on local immunoregulation with a particular relevance for late transplantation immunobiology.
BibTeX
@misc{cippa2018late,
  author = {Pietro E. Cippà and Jing Liu and Bo Sun and Sanjeev Kumar and Maarten Naesens and Andrew P. McMahon},
  title = {{Late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation}},
  year = {2018},
  doi = {10.1101/343012},
  howpublished = {bioRxiv},
}
Figure